Comparison of adverse events between cluster and conventional immunotherapy for allergic rhinitis patients with or without asthma: A systematic review and meta-analysis
ConclusionOur data suggest that cluster schedule is as safe as or even safer than conventional schedule for AR patients with or without asthma (AS).
Source: American Journal of Otolaryngology - Category: Endocrinology Source Type: research
More News: Allergy & Immunology | Asthma | China Health | Endocrinology | Hay Fever | Immunotherapy | Men | SARS | Study